Le Lézard
Classified in: Health, Business
Subjects: CXP, MAT

Trulieve Announces Opening of Affiliated Medical Marijuana Dispensary in Limerick, PA


New dispensary expands patient access to medical cannabis with ribbon cutting and pop-up event

TALLAHASSEE, Fla., May 19, 2023 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced the grand opening of a new Trulieve-affiliated medical marijuana dispensary in Limerick, PA. Located at 451 West Ridge Pike, the doors will open 9 AM on Friday, May 19, 2023 with ongoing hours of 9 AM - 10 PM, seven days a week.

"Pennsylvania is one of the strongest medical markets in America," said Trulieve's Chief Executive Officer Kim Rivers. "We are proud to serve customers by offering quality products, first-class service and convenient locations throughout Pennsylvania." 

Trulieve invites the Limerick community to join in celebrating this new affiliated medical marijuana dispensary on Friday, May 19 with a ribbon cutting, partner giveaways, special discounts and more starting at 9 AM.

Additional Trulieve-affiliated dispensaries in Pennsylvania communities, including: Camp Hill, Coatesville, Cranberry Township, Devon, Harrisburg, Johnstown, King of Prussia, Philadelphia, Philadelphia Charter City, Philadelphia Washington Square, Pittsburgh, Pittsburgh North Shore, Reading (on Lancaster), Reading (on 5th St. Hwy), Scranton, Washington, Whitehall, York and Zelienople.

To find a location or to learn how to become a registered patient, visit Trulieve.com, follow us on Instagram at trulieve_pa or connect with Trulieve PA on Facebook.

About Trulieve 

Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve 
Instagram: @Trulieve_ 
Twitter: @Trulieve 

Investor Contact
Christine Hersey, Vice President of Investor Relations
+1 (424) 202-0210
[email protected]

Media Contact
Nicole Yelland, Executive Director of Corporate Communications
+1 (248) 219-9234
[email protected] 

 

SOURCE Trulieve Cannabis Corp.


These press releases may also interest you

at 15:39
The Government of Canada is committed to upholding Canada's high safety standards for food and animal feed, while maintaining market access for Canadian producers. Today, the Canadian Food Inspection Agency (CFIA) has announced the publication of...

at 15:30
The professional membership group of the American Hospital Association focused on healthcare marketing has enlisted experts from the advertising agency universe and the provider data sector to share insights about the best methods for reaching and...

at 15:20
Team famous for HIV breakthroughs demonstrates both persistent COVID virus and widespread immune activation in long COVID; provides clear targets for treatment Key points: SARS-CoV-2 double-stranded RNA indicative of viral replication was found in...

at 15:05
CloudMD Software & Services Inc. (the "Company" or "CloudMD"), an innovative health services company transforming the delivery of care, is pleased to announce that it has received a final order from the Supreme Court of British Columbia approving...

at 14:57
Workers at Watsonville Community Hospital represented by Teamsters Local 853 have voted unanimously to ratify a collective bargaining agreement. The new three-year contract includes significant wage increases, a strong benefits package with Teamsters...

at 14:55
The global anti-inflammatory therapeutics market size is estimated to grow by USD 38.7 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 6.3% during the forecast period. Increase in off-label use is...



News published on and distributed by: